STUDY SEARCH RESULTS

17 studies found for your search request:  vaccines

A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent human papillomavirus vaccine ...
Condition: Papillomavirus infections
Minimum Age: 9 years, Maximum Age: 15 years
Gender: Female
Study ID: NCT01254643
Status: Completed

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU...
Condition: Pneumococcal infections
Minimum Age: 42 days, Maximum Age: 90 days
Gender: All
Study ID: NCT03620162
Status: Completed

Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
Condition: Rotavirus gastroenteritis
Minimum Age: 6 weeks, Maximum Age: 12 weeks
Gender: Both
Study ID: NCT02062385
Status: Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumova...
Condition: Pneumococcal infections
Minimum Age: 50 years, Maximum Age: N/A
Gender: Both
Study ID: NCT02225587
Status: Completed

Immunogenicity and Safety of V419 (PR51) in Combination with MCC in Infants and Toddlers (V419-011)
Condition: Neisseria meningitidis, Bacterial infections, Virus diseases
Minimum Age: 46 days, Maximum Age: 74 days
Gender: Both
Study ID: NCT01553279
Status: Completed
Has Results




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site